{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:17:16Z","timestamp":1790882236731,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Age-related macular degeneration (AMD), in which oxidative stress, inflammation and metabolic imbalances play a role in its pathogenesis, is one of the leading causes of irreversible vision loss. The kynurenine (KYN) pathway, one of the principal routes of tryptophan (TRP) metabolism, constitutes an important mechanism in retinal neurodegeneration. Based on this information, our study aimed to compare the serum TRP, KYN, kynurenic acid (KYNA), 3-hydroxykynurenine (3HK), 3-hydroxyanthranilic acid (3HAA) and, quinolinic acid (QA) levels of AMD patients and to investigate the diagnostic values \u200b\u200bof these biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum samples were collected from AMD patients and control groups. TRP, KYN, KYNA, 3HK, 3HAA, and QA levels were measured using a commercial ELISA method. KYN pathway activity, KYN\/TRP and, KYNA\/3HK ratios were also assessed. Mann-Whitney U test, ROC analysis, Spearman correlation were applied for statistical comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>According to our results, 3HK was significantly higher in the AMD group, while TRP, KYN, QA, and KYNA\/3HK ratio were higher in the control. ROC analysis revealed 3HK to be the strongest discriminatory marker. The KYNA\/3HK ratio also provided significant diagnostic value. Correlation analysis revealed strong negative correlations between 3HK and KYN, QA, and especially KYNA\/3HK. Conversely, strong positive correlations were found between KYN and KYNA\/3HK, and between TRP, KYN, QA, and KYNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>KYN pathway metabolites exhibit significant alterations in patients with AMD. 3HK levels and the reduction of the KYNA\/3HK ratio suggest a disruption of the neurotoxic\u2013neuroprotective balance and imply that KYN pathway dysfunction may play a role in the pathogenesis of AMD. Among the biomarkers examined, 3HK displayed the highest diagnostic performance, while the KYNA\/3HK ratio emerged as an additional biological indicator. These findings indicate that 3HK and the KYNA\/3HK ratio may serve as potential biomarker candidates for the early diagnosis and monitoring of AMD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00757-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:49:05Z","timestamp":1764330545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kynurenine pathway metabolites as potential biomarkers in age-related macular degeneration: an ELISA-based prospective study"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-189X","authenticated-orcid":false,"given":"Ahmet","family":"Dundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-5343","authenticated-orcid":false,"given":"Songul","family":"Cetik Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"16","key":"757_CR1","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/cells12162092","volume":"12","author":"GA Borchert","year":"2023","unstructured":"Borchert GA, Shamsnajafabadi H, Hu ML, De Silva SR, Downes SM, MacLaren RE, et al. The role of inflammation in age-related macular degeneration-therapeutic landscapes in geographic atrophy. Cells. 2023;12(16):2092. https:\/\/doi.org\/10.3390\/cells12162092.","journal-title":"Cells"},{"issue":"3","key":"757_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms22031296","volume":"22","author":"Y Ruan","year":"2021","unstructured":"Ruan Y, Jiang S, Gericke A. Age-related macular degeneration: role of oxidative stress and blood vessels. Int J Mol Sci. 2021;22(3):1296. https:\/\/doi.org\/10.3390\/ijms22031296.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"757_CR3","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3390\/ijms24065742","volume":"24","author":"A Tsuji","year":"2023","unstructured":"Tsuji A, Ikeda Y, Yoshikawa S, Taniguchi K, Sawamura H, Morikawa S, et al. The Tryptophan and kynurenine pathway involved in the development of immune-related diseases. Int J Mol Sci. 2023;24(6):5742. https:\/\/doi.org\/10.3390\/ijms24065742.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"757_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom12070998","volume":"12","author":"K Hestad","year":"2022","unstructured":"Hestad K, Alexander J, Rootwelt H, Aaseth JO. The role of Tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules. 2022;12(7):998. https:\/\/doi.org\/10.3390\/biom12070998.","journal-title":"Biomolecules"},{"issue":"3","key":"757_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/metabo15030210","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang Y, Wang W, Zhang Y, Dong X, Liu Y. Diverse physiological roles of kynurenine pathway metabolites: updated implications for health and disease. Metabolites. 2025;15(3):210. https:\/\/doi.org\/10.3390\/metabo15030210.","journal-title":"Metabolites"},{"key":"757_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","volume":"7","author":"MD Lovelace","year":"2016","unstructured":"Lovelace MD, Varney B, Sundaram G, Franco NF, Ng ML, Pai S, et al. Current evidence for a role of the kynurenine pathway of Tryptophan metabolism in multiple sclerosis. Front Immunol. 2016;7:246. https:\/\/doi.org\/10.3389\/fimmu.2016.00246.","journal-title":"Front Immunol"},{"issue":"10","key":"757_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3389\/fphys.2019","volume":"1","author":"M Fiedorowicz","year":"2019","unstructured":"Fiedorowicz M, Choragiewicz T, Thaler S, Schuettauf F, Nowakowska D, Wojtunik K, et al. Tryptophan and kynurenine pathway metabolites in animal models of retinal and optic nerve damage: different dynamics of changes. Front Physiol. 2019;1(10):1254. https:\/\/doi.org\/10.3389\/fphys.2019.","journal-title":"Front Physiol"},{"issue":"1","key":"757_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ophtha.2019.09.024","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. age-related macular degeneration preferred practice pattern. Ophthalmology. 2020;127(1):1\u201365. https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.024.","journal-title":"Ophthalmology"},{"issue":"7","key":"757_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/pcn.13819","volume":"79","author":"HH Alp","year":"2025","unstructured":"Alp HH, Kurhan F, Akbay H\u0130. Predictive value of kynurenine pathway metabolites in the severity of patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2025;79(7):378\u201388. https:\/\/doi.org\/10.1111\/pcn.13819.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"12","key":"757_CR10","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.55563\/clinexprheumatol\/cp4st9","volume":"41","author":"Y Park","year":"2023","unstructured":"Park Y, Lee JJ, Koh JH, Kim MJ, Park SH, Kwok SK. Kynurenine pathway can be a potential biomarker of fatigue in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2023;41(12):2363\u201370. https:\/\/doi.org\/10.55563\/clinexprheumatol\/cp4st9.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"757_CR11","doi-asserted-by":"publisher","first-page":"e13739","DOI":"10.1111\/ijcp.13739","volume":"75","author":"M Ozturk","year":"2021","unstructured":"Ozturk M, Yal\u0131n Sapmaz S, Kandemir H, Taneli F, Aydemir O. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder. Int J Clin Pract. 2021;75(4):e13739. https:\/\/doi.org\/10.1111\/ijcp.13739.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"757_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/medicina59111906","volume":"59","author":"V Yildirim","year":"2023","unstructured":"Yildirim V, Simsek S, Cetin I, Dokuyucu R. Kynurenine, kynurenic acid, quinolinic acid and interleukin-6 levels in the serum of patients with autism spectrum disorder. Med (Kaunas). 2023;59(11):1906. https:\/\/doi.org\/10.3390\/medicina59111906.","journal-title":"Med (Kaunas)"},{"issue":"8","key":"757_CR13","doi-asserted-by":"publisher","first-page":"e41599","DOI":"10.1097\/MD.0000000000041599","volume":"104","author":"R Babaker","year":"2025","unstructured":"Babaker R, Alzimami L, Al Ameer A, Almutairi M, Aldeen RA, Alshatti H, et al. Risk factors for age-related macular degeneration: updated systematic review and meta-analysis. Medicine. 2025;104(8):e41599. https:\/\/doi.org\/10.1097\/MD.0000000000041599.","journal-title":"Medicine"},{"issue":"3","key":"757_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology. 2012;119(3):571\u201380. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.027.","journal-title":"Ophthalmology"},{"issue":"12","key":"757_CR15","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","volume":"124","author":"JM Colijn","year":"2017","unstructured":"Colijn JM, Buitendijk GHS, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP, et al. Prevalence of age-related macular degeneration in europe: the past and the future. Ophthalmology. 2017;124(12):1753\u201363. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.035.","journal-title":"Ophthalmology"},{"issue":"6","key":"757_CR16","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.3390\/ijms24066010","volume":"24","author":"ML Pais","year":"2023","unstructured":"Pais ML, Martins J, Castelo-Branco M, Gon\u00e7alves J. Sex differences in Tryptophan metabolism: A systematic review focused on neuropsychiatric disorders. Int J Mol Sci. 2023;24(6):6010. https:\/\/doi.org\/10.3390\/ijms24066010.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"757_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/1120672120927256","volume":"31","author":"X Lin","year":"2021","unstructured":"Lin X, Lou L, Miao Q, Wang Y, Jin K, Shan P, et al. The pattern and gender disparity in global burden of age-related macular degeneration. Eur J Ophthalmol. 2021;31(3):1161\u201370. https:\/\/doi.org\/10.1177\/1120672120927256.","journal-title":"Eur J Ophthalmol"},{"key":"757_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","volume":"34","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2013","unstructured":"Col\u00edn-Gonz\u00e1lez AL, Maldonado PD, Abel Santamar\u00eda A. 3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system. Neurotoxicology. 2013;34:189\u2013204. https:\/\/doi.org\/10.1016\/j.neuro.2012.11.007.","journal-title":"Neurotoxicology"},{"issue":"3","key":"757_CR19","doi-asserted-by":"publisher","first-page":"e1010644","DOI":"10.1371\/journal.pgen.1010644","volume":"19","author":"S Hebbar","year":"2023","unstructured":"Hebbar S, Traikov S, Halsig C, Knust E. Modulating the kynurenine pathway or sequestering toxic 3-hydroxykynurenine protects the retina from light-induced damage in drosophila. PLoS Genet. 2023;19(3):e1010644. https:\/\/doi.org\/10.1371\/journal.pgen.1010644.","journal-title":"PLoS Genet"},{"key":"757_CR20","doi-asserted-by":"publisher","unstructured":"Braidy N, Grant R, Brew BJ, Adams S, Jayasena T, Guillemin GJ. Effects of kynurenine pathway metabolites on intracellular NAD\u2009+\u2009synthesis and cell death in human primary astrocytes and neurons. IJTR. 2009;2. https:\/\/doi.org\/10.4137\/IJTR.S2318.","DOI":"10.4137\/IJTR.S2318"},{"issue":"4","key":"757_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","volume":"263","author":"MJ Schwarz","year":"2013","unstructured":"Schwarz MJ, Guillemin GJ, Teipel SJ, Buerger K, Hampel H. Increased 3-hydroxykynurenine serum concentrations differentiate alzheimer\u2019s disease patients from controls. Eur Arch Psychiatry Clin Neurosci. 2013;263(4):345\u201352. https:\/\/doi.org\/10.1007\/s00406-012-0384-x.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"757_CR22","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1038\/srep41473","volume":"7","author":"C Lim","year":"2017","unstructured":"Lim C, Bilgin A, Lovejoy D, Tan V, Bustamante S, Taylor BV, et al. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep. 2017;7:41473. https:\/\/doi.org\/10.1038\/srep41473.","journal-title":"Sci Rep"},{"key":"757_CR23","doi-asserted-by":"publisher","unstructured":"Schwarcz R, Stone TW. The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology. 2017;112. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003. :237\u2009\u2013\u200947.","DOI":"10.1016\/j.neuropharm.2016.08.003"},{"key":"757_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/ijtr.s2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res. 2009;2:1\u201319. https:\/\/doi.org\/10.4137\/ijtr.s2097.","journal-title":"Int J Tryptophan Res"},{"key":"757_CR25","doi-asserted-by":"publisher","first-page":"104024","DOI":"10.1155\/2013\/104024","volume":"2013","author":"R Lugo-Huitr\u00f3n","year":"2013","unstructured":"Lugo-Huitr\u00f3n R, Ugalde Mu\u00f1iz P, Pineda B, Pedraza-Chaverr\u00ed J, R\u00edos C. P\u00e9rez-de La CV. Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxid Med Cell Longev. 2013;2013:104024. https:\/\/doi.org\/10.1155\/2013\/104024.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"757_CR26","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","volume":"10","author":"E Wirthgen","year":"2018","unstructured":"Wirthgen E, Hoeflich A, Rebl A, G\u00fcnther J. Kynurenic acid: the janus-faced role of an Immunomodulatory Tryptophan metabolite and its link to pathological conditions. Front Immunol. 2018;10(8):1957. https:\/\/doi.org\/10.3389\/fimmu.2017.01957.","journal-title":"Front Immunol"},{"issue":"12","key":"757_CR27","doi-asserted-by":"publisher","first-page":"117864691986897","DOI":"10.1177\/1178646919868978","volume":"21","author":"AA Badawy","year":"2019","unstructured":"Badawy AA, Guillemin G. The plasma [kynurenine]\/[tryptophan] ratio and indoleamine 2,3-dioxygenase: time for appraisal. Int J Tryptophan Res. 2019;21(12):1178646919868978. https:\/\/doi.org\/10.1177\/1178646919868978.","journal-title":"Int J Tryptophan Res"},{"issue":"8","key":"757_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279(8):1356\u201365. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08485.x.","journal-title":"FEBS J"},{"issue":"1","key":"757_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1471-4159.2011.07414.x","volume":"119","author":"CM Forrest","year":"2011","unstructured":"Forrest CM, Mackay GM, Oxford L, Millar K, Darlington LG, Higgins MJ, et al. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery. J Neurochem. 2011;119(1):136\u201352. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07414.x.","journal-title":"J Neurochem"},{"issue":"13","key":"757_CR30","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.3390\/jcm14134529","volume":"14","author":"A Zemitis","year":"2025","unstructured":"Zemitis A, Vanags J, Klavins K, Laganovska G. Assessment of kynurenine pathway enzyme activity in ocular diseases: associations with cataract, diabetes, glaucoma, and pseudoexfoliation syndrome. J Clin Med. 2025;14(13):4529. https:\/\/doi.org\/10.3390\/jcm14134529.","journal-title":"J Clin Med"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:49:05Z","timestamp":1764330545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00757-3","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mardin Artuklu University Non-Interventional Clinical Research Ethics Committee (number: 2025\/2\u20134, date: 18.02.2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent forms (signed) were obtained from the all patients and control group. Our study complies with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}